These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33803277)

  • 1. Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics.
    Calsolaro V; Femminella GD; Rogani S; Esposito S; Franchi R; Okoye C; Rengo G; Monzani F
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33803277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Antipsychotics in Patients with Behavioral and Psychological Symptoms of Dementia: Results of a Spanish Delphi Consensus.
    Manzano-Palomo S; Agüera-Ortiz LF; García-Caballero A; Martínez-Raga J; Ojea-Ortega T; Sánchez-Valle R; Antón-Jiménez M; Monge-Argilés JA; Ramos-García I
    Dement Geriatr Cogn Disord; 2020; 49(6):573-582. PubMed ID: 33176326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD).
    Liperoti R; Pedone C; Corsonello A
    Curr Neuropharmacol; 2008 Jun; 6(2):117-24. PubMed ID: 19305792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects.
    Ohno Y; Kunisawa N; Shimizu S
    Front Pharmacol; 2019; 10():1045. PubMed ID: 31607910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics in the management of behavioral symptoms associated with dementia.
    González-Concepción JJ; Geil K; Jiménez-Velázquez IZ; Ramos-Romey C
    Bol Asoc Med P R; 2009; 101(1):51-3. PubMed ID: 19954089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recognition and treatment of behavioral and psychological symptoms of dementias: lessons from the CATIE-AD study].
    Kálmán J; Kálmán S; Pákáski M
    Neuropsychopharmacol Hung; 2008 Oct; 10(4):233-49. PubMed ID: 19213202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis.
    Yunusa I; Alsumali A; Garba AE; Regestein QR; Eguale T
    JAMA Netw Open; 2019 Mar; 2(3):e190828. PubMed ID: 30901041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Perception and Treatment Options for Behavioral and Psychological Symptoms of Dementia (BPSD) in Italy.
    D'Antonio F; Tremolizzo L; Zuffi M; Pomati S; Farina E;
    Front Psychiatry; 2022; 13():843088. PubMed ID: 35432010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Narrative Review of Studies Comparing Efficacy and Safety of Citalopram with Atypical Antipsychotics for Agitation in Behavioral and Psychological Symptoms of Dementia (BPSD).
    Qasim HS; Simpson MD
    Pharmacy (Basel); 2022 Jun; 10(3):. PubMed ID: 35736776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
    Angelini A; Bendini C; Neviani F; Neri M
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():35-43. PubMed ID: 17317431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.
    Zaudig M
    Drug Saf; 2000 Sep; 23(3):183-95. PubMed ID: 11005702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].
    Pinheiro D
    Encephale; 2008 Sep; 34(4):409-15. PubMed ID: 18922244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress.
    Magierski R; Sobow T; Schwertner E; Religa D
    Front Pharmacol; 2020; 11():1168. PubMed ID: 32848775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of atypical antipsychotics for behavioral symptoms of dementia among patients residing in long-term care.
    Sturm AS; Trinkley KE; Porter K; Nahata MC
    Int J Clin Pharm; 2018 Feb; 40(1):135-142. PubMed ID: 29189977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?
    Herrmann N; Lanctôt KL
    Drug Saf; 2006; 29(10):833-43. PubMed ID: 16970508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer's Disease.
    Calsolaro V; Antognoli R; Okoye C; Monzani F
    Front Pharmacol; 2019; 10():1465. PubMed ID: 31920655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events.
    van Iersel MB; Zuidema SU; Koopmans RT; Verhey FR; Olde Rikkert MG
    Drugs Aging; 2005; 22(10):845-58. PubMed ID: 16245958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
    Lawlor BA
    J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.
    Cerovecki A; Musil R; Klimke A; Seemüller F; Haen E; Schennach R; Kühn KU; Volz HP; Riedel M
    CNS Drugs; 2013 Jul; 27(7):545-72. PubMed ID: 23821039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.